Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > non-capped the ACB buyout is worth $63 per CMED shares!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by PROtradingon Jan 03, 2018 5:18pm
62 Views
Post# 27274575

RE:RE:RE:RE:non-capped the ACB buyout is worth $63 per CMED shares!

RE:RE:RE:RE:non-capped the ACB buyout is worth $63 per CMED shares!Look GarlicToast, you made a FOOL out of yourself again on that Aurora pumped bullboard by not knowing how to check the trading volumes on stocks.  Now you're one of the huff and puff little kiddies with basement and mommy fetishes!!!  LMAO!!!

Your level of intelligence indicates you are a paid Aurora shill or some teenager all gaga over that Aurora pump and dump? 

**** Well get this, $63 for CMED ***  Tell your boss at Aurora, we'll take the 4.53 for 1 deal UNCAPPED but we have to hold our noses!!!!

And that's only conditional that Cannidmed shareholders aren't locked up because once the music stops at that musical chair weed play, OUCH!!!!

We want to be able to DUMP the PUMP AND DUMP Aurora as soon as CMED shares are converted to that bloated pig of yours BEFORE it crashes ok!   LOL 

Bye bye kiddy.  Say hi to your mommy and if she's hot, have her contact me ok?  LOL
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities